埃塞俄比亚心力衰竭成年人的伴随性抑郁症:基于医院的横截面研究
Henok Mulugeta1,2, Peter M Sinclair3, Amanda Wilson3
1Department of Nursing, College of Health Sciences, Debre Markos University, Debre Markos, Amhara Region, Ethiopia. mulugetahenok68@gmail.com.
BMC psychiatry
|April 25, 2024
概括
在埃塞俄比亚,超过一半心力衰竭的成年人患有抑郁症,影响生活质量. 关键因素包括女性性别,糖尿病,晚期心力衰竭,社会支持不足和多药.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 抑郁症是心力衰竭患者常见的并发症,与不良的临床结果有关.
- 关于埃塞俄比亚心力衰竭患者抑郁症患病率的数据有限.
- 这项研究解决了这一群体中有关并发性抑郁症的数据缺口.
研究的目的:
- 确定埃塞俄比亚心力衰竭成年人中抑郁症的流行率.
- 在这个患者群体中确定与伴随性抑郁症相关的因素.
主要方法:
- 在埃塞俄比亚的亚的斯亚贝巴进行了一项基于医院的横截面研究.
- 从383名心力衰竭患者收集数据,使用面试官管理的问卷.
- 使用患者健康问卷 (PHQ-9) 评估抑郁症,后勤回归确定了相关因素.
主要成果:
- 伴随性抑郁症的患病率为56.6% (95% CI:51.53-61.68).
- 与抑郁症显著相关的因素包括女性性别,糖尿病,NYHA IV类,社会支持不足,服用超过五种药物.
- 平均PHQ-9得分表明中度抑郁症.
结论:
- 在埃塞俄比亚,超过一半的心力衰竭成年人患有并发性抑郁症.
- 识别和解决相关因素对于改善治疗结果和生活质量至关重要.
- 建议进行进一步的研究,包括干预和定性研究,以开发多方面的方法来管理心力衰竭中的抑郁症.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Depressive Disorders: Etiology
71
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
71
Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
Depressive Disorders: MDD and Dysthymia
105
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
105
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227


